1 of 1
Story summary
- The US National Institute of Allergy and Infectious Diseases (NIAID) is restructuring to deprioritize biodefense and pandemic preparedness, with staff instructed to remove related terms from web pages.
- Acting director Jeffery Taubenberger and NIH officials say the agency will prioritize basic immunology and current infectious diseases affecting Americans.
- Nature Medicine notes the plan includes reviewing NIAID's funding portfolio, while critics like Nahid Bhadelia warn the public could become more vulnerable.
